Detalles de la búsqueda
1.
Iodoquinazoline-derived VEGFR-2 and EGFRT790M dual inhibitors: Design, synthesis, molecular docking and anticancer evaluations.
Bioorg Chem
; 143: 107062, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38150938
2.
Modulation of NRF2/KEAP1-Mediated Oxidative Stress for Cancer Treatment by Natural Products Using Pharmacophore-Based Screening, Molecular Docking, and Molecular Dynamics Studies.
Molecules
; 28(16)2023 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37630254
3.
Role of CD44 in Regulating TLR2 Activation of Human Macrophages and Downstream Expression of Proinflammatory Cytokines.
J Immunol
; 200(2): 758-767, 2018 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29196459
4.
Anticancer evaluations of iodoquinazoline substituted with allyl and/or benzyl as dual inhibitors of EGFRWT and EGFRT790M: design, synthesis, ADMET and molecular docking.
RSC Adv
; 14(12): 7964-7980, 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38454937
5.
Exploring the potential of approved drugs for triple-negative breast cancer treatment by targeting casein kinase 2: Insights from computational studies.
PLoS One
; 18(8): e0289887, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37578958
6.
Design, synthesis, docking, ADMET and anticancer evaluations of N-alkyl substituted iodoquinazoline derivatives as dual VEGFR-2 and EGFR inhibitors.
RSC Adv
; 13(51): 36301-36321, 2023 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38093733
Resultados
1 -
6
de 6
1
Próxima >
>>